Cytokine Profiles of Head and Neck Squamous Cell Carcinoma Undergoing Dual Immunotherapy With Cetuximab and Pembrolizumab Identify Interferon Gamma-Induced Protein 10 as Novel Biomarker

BACKGROUND: Pembrolizumab and cetuximab are antibodies under investigation in head and neck squamous cell carcinoma (HNSCC) either as single agents or combined with cisplatin and other chemotherapeutic drugs, e.g., 5-fluorouracil and/or docetaxel. However, also the combination of both antibodies may...

Descripción completa

Detalles Bibliográficos
Autores principales: Berszin, Michael, Michaelides, Ioannis, Siemert, Julia, Röhl, Louisa, Wellhausen, Jana, Wald, Theresa, Bohr, Christopher, Künzel, Julian, Gradistanac, Tanja, Dietz, Andreas, Zebralla, Veit, Pirlich, Markus, Wiegand, Susanne, Wichmann, Gunnar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918678/
https://www.ncbi.nlm.nih.gov/pubmed/35296001
http://dx.doi.org/10.3389/fonc.2022.795277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918678/
https://www.ncbi.nlm.nih.gov/pubmed/35296001
http://dx.doi.org/10.3389/fonc.2022.795277

Ejemplares similares